Pharma Industry News

Novel micro-RNA therapeutic hits early targets in ischemic heart diseases

Earlier this year, Horizon announced a new collaboration and license agreement with Mammoth Biosciences.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]